![Christopher Cargill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 724 391 $ as of 31/07/2026
Christopher Robert Cargill is currently Director at Nxera Pharma Japan Co., Ltd. Formerly, Mr. Cargill was Director at Sosei R&D Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products 0.14% | 31/12/2025 | 131,668 ( 0.14% ) | 724 391 $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells daridorexants | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Idorsia Pharmaceuticals Japan Ltd.
Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells daridorexants | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
